Adrian Murray Brunt - Publications, H-index & Citations

Adrian Murray Brunt

Institute of Cancer Research

25H指数

130论文数

5.4K被引数

收录论文 43

发表时间

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy 1周与3周低分割乳腺癌放疗（FAST-Forward）：一项多中心、开放标签、非劣效性、III期随机对照试验的10年疗效和晚期正常组织效应，以及随机腋窝亚研究的5年疗效结果

Lancet Oncology

IF35.9

2026-05-14

OAAI

Adrian Murray Brunt; Fay H Cafferty; Anna M Kirby; Jaymini Patel; Mark A Sydenham; Joanne S Haviland; Susan Griffin; Carlos Chivardi; Helen Fleming; Charlotte E Coles; David J Bloomfield; Charlie Chan; Susan Cleator; Andy Goodman; Clare L Griffin; Cliona C Kirwan; Zohal Nabi; Elinor Sawyer; Navita Somaiah; Isabel Syndikus

Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-study 乳腺癌FAST-Forward试验淋巴结亚研究中手术和放疗患者上肢肿胀的相关因素

Radiotherapy and Oncology

IF5.3

2026-04-30

OAAI

Saranya Ravindra; Fay H. Cafferty; Emma Harris; Sarah Gulliford; Elizabeth Miles; Jaymini Patel; Mark A. Sydenham; Sambhav Kumar; Zohal Nabi; Sarah Mason; Simeon Nill; Alex Dunlop; A. Murray Brunt; Judith M. Bliss; Anna M. Kirby

Commentary on “Further data to enhance clinical integration of nodal hypofractionation: A commentary on the FAST-Forward nodal sub-study”对“进一步数据以增强淋巴结低分割的临床整合：FAST-Forward淋巴结亚组研究的评论”的评论

Radiotherapy and Oncology

IF5.3

2025-07-09

PREAI

A. Murray Brunt; Fay H. Cafferty; Anna M. Kirby; Charlotte E. Coles; Judith M. Bliss

Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial 早期乳腺癌女性保乳手术后的部分乳腺放射治疗（UK IMPORT LOW）：一项多中心、开放标签、随机对照、III期非劣效性试验的10年结果

lancet oncology

IF0

2025-06-11

OAAI

Anna M Kirby; Laura Finneran; Clare L Griffin; Adrian M Brunt; Fay H Cafferty; Abdulla Alhasso; Charlie Chan; Joanne S Haviland; Monica L Jefford; Elinor J Sawyer; Mark A Sydenham; Isabel Syndikus; Yat M Tsang; Duncan Wheatley; John R Yarnold; Charlotte E Coles; Judith M Bliss

Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study 患者和临床医生评估的五年正常组织效应：比较乳腺癌患者接受一周期与三周期腋窝放疗的结果——来自III期FAST-Forward试验随机淋巴结亚组研究

RADIOTHERAPY AND ONCOLOGY

IF5.3

2025-06-01

OAAI

Brunt, A. Murray; Cafferty, Fay H.; Wheatley, Duncan; Sydenham, Mark A.; Kirby, Anna M.; Coles, Charlotte E.; Patel, Jaymini; Alhasso, Abdulla; Chan, Charlie; Cleator, Susan; Fleming, Helen; Gahir, Daljit; Goodman, Andy; Griffin, Clare; Haviland, Joanne S.; Kirwan, Cliona; Nabi, Zohal; Poole, Karen; Sawyer, Elinor; Sinclair, Judith; Somaiah, Navita; Syndikus, Isabel; Venables, Karen; Yarnold, John; Bliss, Judith M.

Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy 区域淋巴结勾画变异及其在乳腺癌放射治疗中的剂量影响

CLINICAL ONCOLOGY

IF3

2025-06-01

PREAI

Nabi, Z.; Megias, D.; Diez, P.; Caraman, A.; Mir, R.; Wheatley, D.; Maclennan, M.; Bliss, J.; Haviland, J.; Sydenham, M. A.; Spezi, E.; Tsang, Y.; Brunt, A. M.

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT 一周和三周大分割全乳腺放疗治疗早期乳腺癌: 快进III期RCT

HEALTH TECHNOLOGY ASSESSMENT

IF4

2023-11-01

OAAI

Brunt, Adrian Murray; Haviland, Joanne S.; Wheatley, Duncan A.; Sydenham, Mark A.; Bloomfield, David J.; Chan, Charlie; Cleator, Suzy; Coles, Charlotte E.; Donovan, Ellen; Fleming, Helen; Glynn, David; Goodman, Andrew; Griffin, Susan; Hopwood, Penelope; Kirby, Anna M.; Kirwan, Cliona C.; Nabi, Zohal; Patel, Jaymini; Sawyer, Elinor; Somaiah, Navita; Syndikus, Isabel; Venables, Karen; Yarnold, John R.; Bliss, Judith M.

Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity

CLINICAL ONCOLOGY

IF3

2023-06-01

OAAI

Fernando, I. N.; Lax, S.; Bowden, S. J.; Ahmed, I.; Steven, J. H.; Churn, M.; Brunt, A. M.; Agrawal, R. K.; Canney, P.; Stevens, A.; Rea, D. W.

Hypofractionation: The standard for external beam breast irradiation

BREAST

IF7.9

2023-06-01

OAAI

Brunt, Adrian Murray; Haviland, Joanne Susan

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

LANCET

IF88.5

2023-06-01

OAAI

Coles, Charlotte E.; Haviland, Joanne S.; Kirby, Anna M.; Griffin, Clare L.; Sydenham, Mark A.; Titley, Jenny C.; Bhattacharya, Indrani; Brunt, A. Murray; Chan, H. Y. Charlie; Donovan, Ellen M.; Eaton, David J.; Emson, Marie; Hopwood, Penny; Jefford, Monica L.; Lightowlers, Sara, V; Sawyer, Elinor J.; Syndikus, Isabel; Tsang, Yat M.; Twyman, Nicola, I; Yarnold, John R.; Bliss, Judith M.

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study

BREAST CANCER RESEARCH AND TREATMENT

IF3

2023-03-02

OAAI

Oswald, Ailsa J.; Symeonides, Stefan N.; Wheatley, Duncan; Chan, Stephen; Brunt, Adrian Murray; McAdam, Karen; Schmid, Peter; Waters, Simon; Poole, Christopher; Twelves, Chris; Perren, Timothy; Bartlett, John; Piper, Tammy; Chisholm, Eve Macdonald; Welsh, Michelle; Hill, Robert; Hopcroft, Lisa E. M.; Barrett-Lee, Peter; Cameron, David A.

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis 英国早期乳腺癌5次分割和部分乳腺放疗的成本效益: 基于模型的多试验分析

BREAST CANCER RESEARCH AND TREATMENT

IF3

2022-11-17

OAAI

Glynn, David; Bliss, Judith; Brunt, Adrian Murray; Coles, Charlotte E.; Wheatley, Duncan; Haviland, Joanne S.; Kirby, Anna M.; Longo, Francesco; Faria, Rita; Yarnold, John R.; Griffin, Susan

From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy

CLINICAL ONCOLOGY

IF3

2022-05-01

PREAI

Yarnold, J. R.; Brunt, A. M.; Chatterjee, S.; Somaiah, N.; Kirby, A. M.

Combined peri-operative lapatinib and trastuzumab in early HER2-positive breast cancer - Long term results of the randomized UK EPHOS-B trial

CANCER RESEARCH

IF16.6

2022-02-15

PREAI

Bundred, Nigel; Porta, Nuria; Brunt, Adrian Murray; Cramer, Angela; Hanby, Andrew; Shaaban, Abeer; Rakha, Emad; Armstrong, Anne; Cutress, Ramsey; Dodwell, David; Emson, Marie; Evans, Abigail; Hartup, Sue; Horgan, Kieran; McIntosh, Stuart; Naik, Jay; Narayanan, Samkaran; Oii, Jane; Skene, Anthony; Cameron, David; Bliss, Judith

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

CLINICAL CANCER RESEARCH

IF10.2

2022-02-14

OAAI

Bundred, Nigel; Porta, Nuria; Brunt, Adrian Murray; Cramer, Angela; Hanby, Andrew; Shaaban, Abeer M.; Rakha, Emad A.; Armstrong, Anne; Cutress, Ramsey, I; Dodwell, David; Emson, Marie A.; Evans, Abigail; Hartup, Sue M.; Horgan, Kieran; Miller, Sarah E.; McIntosh, Stuart A.; Morden, James P.; Naik, Jay; Narayanan, Sankaran; Ooi, Jane; Skene, Anthony, I; Cameron, David A.; Bliss, Judith M.

Moving Forward Fast with FAST-Forward

CLINICAL ONCOLOGY

IF3

2021-07-01

OAAI

Lewis, P.; Brunt, A. M.; Coles, C.; Griffin, S.; Locke, I.; Roques, T.

Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation

CLINICAL ONCOLOGY

IF3

2021-07-01

OAAI

Brunt, A. M.; Haviland, J. S.; Kirby, A. M.; Somaiah, N.; Wheatley, D. A.; Bliss, J. M.; Yarnold, J. R.

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

CLINICAL ONCOLOGY

IF3

2020-05-01

191

OAAI

Coles, C. E.; Aristei, C.; Bliss, J.; Boersma, L.; Brunt, A. M.; Chatterjee, S.; Hanna, G.; Jagsi, R.; Person, O. Kaidar; Kirby, A.; Mjaaland, I.; Meattini, I.; Luis, A. M.; Marta, G. N.; Offersen, B.; Poortmans, P.; Rivera, S.

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

LANCET

IF88.5

2020-05-01

676

OAAI

Brunt, Adrian Murray; Haviland, Joanne S.; Wheatley, Duncan A.; Sydenham, Mark A.; Alhasso, Abdulla; Bloomfield, David J.; Chan, Charlie; Churn, Mark; Cleator, Susan; Coles, Charlotte E.; Goodman, Andrew; Harnett, Adrian; Hopwood, Penelope; Kirby, Anna M.; Kirwan, Cliona C.; Morris, Carolyn; Nabi, Zohal; Sawyer, Elinor; Somaiah, Navita; Stones, Liba; Syndikus, Isabel; Bliss, Judith M.; Yarnold, John R.

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

RADIOTHERAPY AND ONCOLOGY

IF5.3

2020-01-01

OAAI

Fernando, Indrajit N.; Bowden, Sarah J.; Herring, Kathryn; Brookes, Cassandra L.; Ahmed, Ikhlaaq; Marshall, Andrea; Grieve, Robert; Churn, Mark; Spooner, David; Latief, Talaat N.; Agrawal, Rajiv K.; Brunt, Adrian M.; Stevens, Andrea; Goodman, Andrew; Canney, Peter; Bishop, Jill; Ritchie, Diana; Dunn, Janet; Poole, Christopher J.; Rea, Daniel W.

研究方向